Figueiredo Pedro, Donato Maria, Urbano Marta, Goulão Helena, Gouveia Hermano, Sofia Carlos, Leitão Maximino, Freitas Diniz
Department of Gastroenterology, Hospitais da Universidade de Coimbra, Avenida Bissaya Barreto, 3000-075 Coimbra, Portugal.
Int J Colorectal Dis. 2009 Apr;24(4):441-50. doi: 10.1007/s00384-008-0576-z. Epub 2008 Sep 4.
Aberrant crypt foci (ACF) are preneoplastic lesions in animal models of colorectal cancer. The aim of the study is to investigate if ACF are involved in human colorectal carcinogenic process and if they can be helpful in predicting the presence of a colorectal neoplasia.
The study included, between 2003 and 2005, 182 patients, 62 with adenoma, 55 with colorectal carcinoma, 53 without colorectal lesions, and 12 with nonneoplastic mucosal polyps. The number of rectal ACF was determined by colonoscopy. Proliferation and apoptosis indexes were evaluated by immunohistochemistry in rectal ACF, in normal rectal mucosa, and in carcinomatous tissue.
The mean number of rectal ACF in patients with rectal neoplasia was 12.64, significantly higher than in patients with neoplastic lesions elsewhere in the colon (p=0.01). The apoptosis index in ACF of patients with colorectal carcinoma or adenoma aged 50 years or older was significantly lower than in younger patients (1.3% vs 2.7%, p=0.01) and, in patients with carcinoma, lower than in normal mucosa (1.1% vs 2.1%, p=0.002). The proliferation index was significantly higher in ACF of patients with colorectal neoplasia aged less than 50 years than in normal mucosa (10.9% vs 7.7%, p=0.02). The apoptosis index in ACF foci of patients with carcinoma (1.1%) was significantly lower than in patients without lesions (2.2%) and than in normal mucosa (2%). The mean number of ACF is significantly higher in patients with polyps larger than 1 cm (11.28 vs 6.27, p=0.02).
Aberrant crypt foci probably precede the appearance of neoplasia and may be helpful in predicting the presence of a colorectal neoplastic lesion.
在结直肠癌动物模型中,异常隐窝灶(ACF)是癌前病变。本研究旨在调查ACF是否参与人类结直肠癌致癌过程,以及它们是否有助于预测结直肠肿瘤的存在。
2003年至2005年期间,本研究纳入了182例患者,其中62例患有腺瘤,55例患有结直肠癌,53例无结直肠病变,12例患有非肿瘤性黏膜息肉。通过结肠镜检查确定直肠ACF的数量。采用免疫组织化学方法评估直肠ACF、正常直肠黏膜和癌组织中的增殖和凋亡指数。
直肠肿瘤患者的直肠ACF平均数量为12.64,显著高于结肠其他部位有肿瘤性病变的患者(p=0.01)。50岁及以上的结直肠癌或腺瘤患者的ACF凋亡指数显著低于年轻患者(1.3%对2.7%,p=0.01),且在癌患者中,低于正常黏膜(1.1%对2.1%,p=0.002)。年龄小于50岁的结直肠肿瘤患者的ACF增殖指数显著高于正常黏膜(10.9%对7.7%,p=0.02)。癌患者的ACF灶凋亡指数(1.1%)显著低于无病变患者(2.2%)和正常黏膜(2%)。息肉大于1 cm的患者的ACF平均数量显著更高(11.28对6.27,p=0.02)。
异常隐窝灶可能先于肿瘤出现,可能有助于预测结直肠肿瘤性病变的存在。